(1.33%) 5 131.48 points
(1.18%) 38 678 points
(2.09%) 16 172 points
(-1.14%) $78.05
(5.85%) $2.15
(-0.09%) $2 307.60
(-0.60%) $26.67
(0.19%) $964.45
(-0.38%) $0.929
(-1.21%) $10.86
(-0.14%) $0.797
(0.36%) $91.46
0.00% $ 0.220
Live Chart Being Loaded With Signals
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally...
Stats | |
---|---|
Volumen de hoy | 906 493 |
Volumen promedio | 1.53M |
Capitalización de mercado | 92.97M |
EPS | $0 ( 2024-02-25 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.00 |
ATR14 | $0.00200 (0.95%) |
Pharmaust Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharmaust Ltd Correlación - Moneda/Commodity
Pharmaust Ltd Finanzas
Annual | 2023 |
Ingresos: | $2.82M |
Beneficio Bruto: | $-929 535 (-32.92 %) |
EPS: | $-0.0194 |
FY | 2023 |
Ingresos: | $2.82M |
Beneficio Bruto: | $-929 535 (-32.92 %) |
EPS: | $-0.0194 |
FY | 2022 |
Ingresos: | $3.38M |
Beneficio Bruto: | $-223 517 (-6.61 %) |
EPS: | $-0.00540 |
FY | 2021 |
Ingresos: | $2.14M |
Beneficio Bruto: | $1.92M (89.47 %) |
EPS: | $-0.00420 |
Financial Reports:
No articles found.
Pharmaust Ltd
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico